Cultivated Rye Pollen Allergy Shots: Secale ≠ Lolium, Pollen ≠ Food
Cultivated rye pollen allergy shots (SCIT) address Secale cereale — the grain crop commonly confused with Lolium perenne (perennial ryegrass), despite being a different genus with a distinct agricultural exposure profile. Rye is wind-pollinated and self-incompatible, producing up to 4 million pollen grains per spike (Fritz & Lukaszewski, 1989) — making it the highest per-plant pollen output of any cereal crop.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
Cultivated Rye Pollenis covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
Cultivated Rye Pollen Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to cultivated rye pollen — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of cultivated rye pollen allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of cultivated rye pollen immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of cultivated rye pollen extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for cultivated rye pollen allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing cultivated rye pollen extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription cultivated rye pollen immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat cultivated rye pollen allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Cultivated Rye Pollen?
The biology, taxonomy, and clinical fingerprint of Cultivated Rye Pollen — the foundation of how SCIT targets it.
Cultivated rye (Secale cereale) spike releasing pollen — rye is wind-pollinated and self-incompatible, producing up to 4 million grains per spike, more than any other cereal crop. Pollen allergy is entirely separate from rye food allergy (secalin gliadins) or gluten sensitivity.
- Scientific name
- Secale cereale
- Family
- Poaceae (Pooideae)Grass family — cool-season Pooideae cereals
- Type
- Annual cool-season cereal crop pollen — wind-pollinated, self-incompatible; occupational aeroallergen
- Native to
- Southwest Asia / Eastern Europe; cultivated globally for grain and cover crops; US acreage concentrated in the Dakotas, Oklahoma, Texas, Kansas, Nebraska, Pennsylvania, and Michigan
- Allergen proteins
- Sec c 1 (major) — Group 1 beta-expansin, primary sensitization markerSec c 5 (major) — Group 5 ribonuclease-like; >85% cross-reactivity with Timothy Phl p 5 (Andersson & Lidholm, 2003)Sec c 12 — profilin (pan-allergen)Sec c 13 — polygalacturonaseSec c 20NOTE: Secale cereale FOOD allergens (secalins/gliadins) are SEED STORAGE PROTEINS — immunologically distinct from pollen allergens and NOT predictive of pollen sensitization
- Particle size
- 40–55 μm
- Avoidance difficulty
- Very difficult
How Cultivated Rye Pollen Allergy Presents
Symptoms by body system — useful for distinguishing Cultivated Rye Pollen sensitivity from overlapping allergies and infections.
Respiratory
- Intense sneezing and rhinorrhea during May–June rye field pollen peak in the Plains and Mid-Atlantic
- Nasal congestion in farmers operating through rye grain fields during flowering
- Asthma exacerbations in grain farmers and elevator workers during peak rye pollen season
- Occupational rhinitis in bakers and millers handling rye grain with residual pollen during processing
- Wheezing from high atmospheric rye pollen counts — rye produces more airborne pollen per acre than any other cereal
Ocular
- Eye itching and tearing during May–June rye pollen season in grain-growing states
- Conjunctival redness in farmworkers during rye field operations at flowering
- Increased ocular sensitivity on dry, windy Plains mornings when rye pollen release is maximal
Dermal
- Contact dermatitis in farmworkers with skin contact with rye stalks during harvesting
- Mild rash in bakers with high-volume occupational skin exposure to rye flour residue
Systemic
- Fatigue from simultaneous rye, Timothy, and orchard grass pollen exposure in May–June
- Reduced farm work capacity during rye flowering operations
- Sleep disruption from nasal congestion during active field work periods
The Lolium-Secale confusion trips up patients and sometimes providers. A patient from rural Oklahoma who shows up with rye sensitization on their panel needs clarification: is this Secale cereale from the grain fields around them, or Lolium perenne from lawn grass? The answer changes the exposure narrative completely. Both are Pooideae and both are covered by a grass mix SCIT, but the relevant avoidance advice is completely different.
When & Where Cultivated Rye Pollen Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: May–June across the Plains and Mid-Atlantic; overlaps with Timothy, orchard grass, and Kentucky bluegrass pollen season· April–July; the May–June peak corresponds to the Plains grain-rye flowering window when atmospheric pollen output is highest
US Exposure Map
8 high-intensity statesExposure intensity by state (text version)
- ME:
- Low
- VT:
- Low
- NH:
- Low
- WA:
- Low
- MT:
- Low
- ND:
- High
- MN:
- Moderate
- WI:
- Moderate
- MI:
- High
- NY:
- Moderate
- MA:
- Low
- OR:
- Low
- ID:
- Low
- WY:
- Low
- SD:
- High
- IA:
- Moderate
- IL:
- Moderate
- IN:
- Moderate
- OH:
- Moderate
- PA:
- High
- NJ:
- Low
- CT:
- Low
- RI:
- Low
- CA:
- Low
- NV:
- Low
- UT:
- Low
- CO:
- Low
- NE:
- High
- MO:
- Low
- KY:
- Low
- WV:
- Low
- VA:
- Moderate
- MD:
- Moderate
- DE:
- Low
- AZ:
- Low
- NM:
- Low
- KS:
- High
- AR:
- Low
- TN:
- Low
- NC:
- Low
- SC:
- Low
- OK:
- High
- LA:
- Low
- MS:
- Low
- AL:
- Low
- GA:
- Low
- TX:
- High
- FL:
- Low
- AK:
- Low
- HI:
- Low
What Cultivated Rye Pollen Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Cultivated rye (Pooideae) shares Sec c 1 and Sec c 5 allergens with the full Pooideae grass cluster, including Timothy, orchard grass, perennial ryegrass, and Kentucky bluegrass — the same Group 1/5 cross-reactivity backbone that makes Pooideae grasses clinically interchangeable for SCIT purposes.
Pooideae — Sec c 5 shows >85% IgE inhibition with Phl p 5 (Andersson & Lidholm, 2003); Timothy SCIT provides strong empirical rye pollen coverage
Pooideae — Lol p 1/5 share high cross-reactivity with Sec c 1/5; note Lolium perenne is a DIFFERENT genus from Secale cereale despite sharing the 'rye' common name
Pooideae cereal — Tri a 1/5 cross-reactivity with Sec c 1/5; coexists in Plains grain farming areas
Pooideae — ~90% Group 1 cross-reactivity; contemporaneous May–July season
Is SCIT Right for Your Cultivated Rye Pollen Allergy?
Answer five questions to assess your candidacy for Pooideae grass SCIT providing cultivated rye pollen coverage.
How severe are your May–June grain field pollen symptoms in Plains or Mid-Atlantic farming areas?
The Cultivated Rye Pollen SCIT Protocol
Cultivated rye pollen SCIT is conducted via a Pooideae grass mix vial — typically Timothy (standardized, 100,000 BAU/mL), Kentucky bluegrass, and/or orchard grass — providing empirical coverage through >85% Sec c 5 / Phl p 5 cross-reactivity. A standalone non-standardized cultivated rye extract (ImmunoCAP g70) is available but is rarely used as monotherapy; the Pooideae mix approach is preferred and more robust.
The Pooideae mix vial escalates from dilute to maintenance concentration under 30-minute post-injection observation. Because the rye pollen season peaks in May–June, beginning build-up in fall or winter allows reaching maintenance before the following cereal planting season. Note: Curex uses a conservative once-weekly build-up schedule and does not offer cluster or rush protocols; traditional clinics may offer cluster options for Plains farmers with long travel distances.
Ongoing maintenance sustains Pooideae tolerance through the May–June rye pollen season and the broader grass pollen window. Agricultural patients often schedule maintenance visits during fall and winter when farm operation intensity permits more regular clinic attendance.
Patients completing a full Pooideae SCIT course typically experience sustained symptom reduction for years after stopping, including during annual rye field operations. Agricultural patients with persistent occupational rye exposure may continue maintenance in consultation with their allergist.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Cultivated Rye Pollen SCIT
No published double-blind placebo-controlled SCIT trial has used cultivated rye (Secale cereale) pollen extract as its primary intervention. Efficacy is extrapolated from the Pooideae grass SCIT evidence base via Sec c 5 cross-reactivity with Phl p 5.
- Grass SCIT symptom score reduction (Pooideae meta-analysis)40%Calderón M et al., 2007, Cochrane Database Syst Rev — broad grass SCIT systematic review
- Timothy SCIT efficacy (Pooideae class reference)82%Frew AJ et al., 2006, JACI meta-analysis — Timothy and Pooideae grass SCIT
- Sec c 5 / Phl p 5 cross-reactivity (IgE inhibition)85%Andersson & Lidholm, 2003, Int Arch Allergy Immunol — Pooideae cereal Group 5 conservation
No cultivated rye SCIT RCT has been published as of 2024. The clinical basis for empirical Pooideae SCIT coverage rests on the well-established >85% Sec c 5 / Phl p 5 IgE cross-reactivity (Andersson & Lidholm, 2003) and the Calderón 2007 Cochrane meta-analysis documenting robust grass SCIT efficacy. The Frew 2006 JACI meta-analysis (82% efficacy for Pooideae SCIT) is the highest-level class evidence applicable to Secale cereale sensitization via the Timothy surrogate.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Cultivated Rye Pollen SCIT Side Effects
Pooideae grass mix SCIT for cultivated rye pollen sensitization carries the standard inhalant SCIT local and systemic reaction profile, managed through the mandatory 30-minute post-injection observation period.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site swelling Wheal and flare at injection arm; resolves within hours | Rate 30–50% | Mild |
Injection-site itching Pruritus at injection site; cold compress provides relief | Rate 25–40% | Mild |
Large local reaction (>25 mm) May require dose adjustment; inform allergist before next visit | Rate 5–10% | Moderate |
Delayed induration Firm lump persisting 24–48 hours; resolves without treatment | Rate 2–5% | Mild |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Nasal/conjunctival flare Brief worsening of baseline pollen allergy symptoms post-injection | Rate 0.5–1% | Mild |
Generalized urticaria Managed with antihistamines; dose reduction at next visit | Rate 0.1–0.3% | Moderate |
Mild bronchospasm More likely in patients with poorly controlled asthma; pre-treatment spirometry recommended for grain workers with occupational asthma | Rate 0.1–0.2% | Moderate |
Systemic anaphylaxis Managed with epinephrine; the first injection from each new vial or concentration is supervised live in the Virtual Shot Room by trained Curex clinical staff, with a prescribed epinephrine auto-injector confirmed on hand | Rate <0.01% | Severe |
No deaths from inhalant SCIT have been reported in the US in the past decade under proper protocols. Pooideae grass mix SCIT carries the well-established safety profile of Timothy-anchored standardized grass immunotherapy. Curex preserves that profile at home with a USP <797> serum, Virtual Shot Room–supervised the first injection from each new vial or concentration, a prescribed epinephrine auto-injector confirmed on hand, and allergist-overseen escalation.
SCIT vs Alternatives for Cultivated Rye Pollen
Plains and Mid-Atlantic farmers and bakers with cultivated rye pollen sensitization have four management options: Pooideae grass SCIT, at-home SLIT drops, occupational personal protective equipment strategies, or seasonal symptom medications.
| Criterion | At-Home SCIT (Curex)Best | SLIT drops/tablets | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Disease-modifying via Pooideae mix; 40–82% class evidence (Calderón 2007, Frew 2006) | Moderate — Grastek (Timothy) covers Pooideae class; custom rye-specific drops available | Moderate — N95 mask + cab filtration during rye operations | Symptom suppression during brief May–Jun season |
| 5-yr cost | $3,500–$10,000 | $1,500–$4,000 | Low direct cost | $200–$1,500 |
| Duration | 3–5 years | 3–5 years | Ongoing seasonal PPE use | Annual 6–8 week course |
| Convenience | At-home self-injection; weekly build-up → monthly | Daily drops at home | Requires PPE discipline during field work | Easy — oral/nasal |
| Safety | <0.01% anaphylaxis; Virtual Shot Room–supervised dosing + prescribed epi | Very low systemic risk | Excellent | Caution: drowsiness risk for farm machinery operators |
| Lasting effect | 7–12+ years post-course | Moderate lasting effect | No disease modification | None — symptoms return each planting season |
At-Home SCIT (Curex)Best
SLIT drops/tablets
Avoidance
Medications
For grain farmers with cultivated rye pollen sensitization, Pooideae SCIT provides the most durable disease-modifying outcome across the full cereal grass season. Curex delivers that SCIT as an at-home allergy shot with pricing confirmed in a current program quote — a Timothy/Pooideae cereal serum (covering the Sec c cross-reactivity spectrum) compounded under USP <797>, with the first injection from each new vial or concentration supervised live in the Virtual Shot Room, a prescribed epinephrine auto-injector confirmed on hand, and allergist-overseen escalation — so eligible farmers reach maintenance without clinic scheduling during the busy spring planting season.
What Cultivated Rye Pollen SCIT Actually Costs
Pooideae grass mix SCIT is covered by most major US insurers under standard allergy benefits. Curex's at-home IgE panel distinguishes Secale (grain rye) pollen sensitization from Lolium (perennial ryegrass) sensitization, providing grain farmers the clinical documentation needed for prior authorization. Agricultural workers may qualify for occupational health allergy coverage pathways through employer insurance plans.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your cultivated rye pollen allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Cultivated Rye Pollen SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Cultivated rye (Secale cereale) and perennial ryegrass (Lolium perenne) are separate genera within the Pooideae subfamily — biologically distinct plants that share only the common-name 'rye.' Secale cereale is the cereal grain crop baked into pumpernickel, rye bread, and rye whiskey, cultivated across Plains and Mid-Atlantic grain-farming states. Lolium perenne is the pasture and lawn grass dominant in the Pacific Northwest (Willamette Valley produces over two-thirds of the world's grass seed) and used for winter overseeding of warm-season lawns. Despite the different exposure contexts, both have Pooideae Group 1 and Group 5 allergens with >85% cross-reactivity, so a Pooideae grass SCIT mix vial provides cross-coverage for both. However, the avoidance guidance differs completely: Secale-sensitized patients need to address grain field exposure; Lolium-sensitized patients need to address lawn and pasture exposure.
No. Rye pollen SCIT addresses aeroallergen sensitization to wind-borne Secale cereale pollen proteins. Rye food allergy is caused by secalin proteins (gliadin homologs) found in rye grain — seed storage proteins immunologically distinct from pollen proteins. These two protein classes do not cross-react, pollen SCIT does not modify food allergen sensitization, and having rye pollen allergy does not predict rye food allergy. Similarly, rye pollen SCIT has no effect on gluten sensitivity or celiac disease, which are T-cell-mediated responses to gliadin proteins — not IgE-mediated. Patients who experience reactions to rye bread should consult a board-certified allergist for oral food challenge evaluation to distinguish true IgE-mediated food allergy from non-IgE gastrointestinal responses.
Cultivated rye (Secale cereale) is wind-pollinated and self-incompatible — meaning individual rye plants cannot fertilize themselves and must rely on pollen transfer between plants to set grain. This biological imperative drives abundant pollen production: Fritz & Lukaszewski (1989, Crop Science) documented up to 4 million pollen grains per rye spike — among the highest per-plant output of any cultivated cereal. In contrast, wheat (Triticum aestivum) is largely self-pollinated (cleistogamous), releasing pollen within closed florets before the flower opens, dramatically reducing airborne pollen output per acre. This production difference means that rye-growing regions experience significantly higher atmospheric cereal pollen loads during May–June than wheat-growing regions of comparable acreage — a clinically important exposure distinction for Plains allergy patients.
Yes, though the occupational allergy risk for bakers and millers is more typically driven by rye flour proteins (high-molecular-weight glutenins, gliadins, secalins) rather than rye pollen — a condition called baker's asthma. Baker's asthma affects approximately 9% of commercial bakers (Houba et al., 1998, Am J Ind Med) and is mediated by inhalation of grain flour proteins, not pollen. However, grain elevator workers and mill workers who handle fresh or recently harvested grain may also be exposed to residual pollen on grain surfaces during the brief post-harvest period. Component IgE testing can distinguish between pollen sensitization (Sec c 1/5 IgE) and flour protein sensitization (secalin/gliadin IgE) in symptomatic grain industry workers, guiding appropriate workplace intervention and immunotherapy planning.
The cultivated rye pollen season is relatively brief compared to perennial grass species — typically 6–8 weeks from approximately late April through June across the Plains and Mid-Atlantic states, with the peak in May and early June when grain rye reaches anthesis (flowering). In the Dakotas and cooler northern planting zones, the season may extend later into June and even early July. Because rye's peak overlaps closely with Timothy, orchard grass, and Kentucky bluegrass pollen seasons, symptomatic patients often experience an extended May–July composite grass pollen burden rather than being able to attribute symptoms to a single species. Monitoring local NAB pollen count data from sites in agricultural counties provides the most accurate regional season tracking for grain farmers managing their exposure.
Rye pollen, as a Pooideae grass with Group 12 profilin (Sec c 12), can theoretically trigger profilin-mediated oral allergy syndrome with certain fresh plant foods — particularly melon, citrus, or kiwi. However, grass-pollen OAS is considerably less clinically prominent than birch-pollen OAS (Bet v 1 / PR-10 class), and most grass-allergic patients do not experience reliable food-triggered OAS reactions. Any profilin-mediated reactions to fresh foods are heat-labile and eliminated by cooking or processing, making dietary avoidance rarely clinically necessary. Rye food allergy — to secalin bread proteins — is an entirely separate immunological entity from grass profilin OAS and from celiac disease. A board-certified allergist can clarify which of these distinct conditions applies based on your symptom history and IgE panel.
Grastek (Timothy SLIT tablet) is FDA-approved for Pooideae grass allergy and provides strong empirical cross-coverage for cultivated rye pollen via Sec c 5 / Phl p 5 cross-reactivity. No FDA-approved SLIT product specifically addresses Secale cereale. Custom sublingual drops can be formulated to include Timothy and other Pooideae components at therapeutic concentrations. Head-to-head comparison between Pooideae SLIT and SCIT for cereal-rye sensitization has not been studied directly. The broader grass SLIT vs. SCIT literature suggests comparable efficacy for Pooideae class allergens, with SCIT having a modest advantage in meta-analyses. For agricultural patients who cannot sustain weekly clinic visits during May planting season, at-home SLIT drops offer a meaningful clinical alternative without the scheduling barrier. Self-administered shots are also well studied: a large safety study of self-administered allergen immunotherapy (Schaffer et al., 2015) found that across 23,614 patients giving 2,021,600 injections, the systemic reaction rate was just 0.16% per patient with no fatalities — lower than the 3%–14% typically seen with office-based shots.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.